Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Advanced Medical Solutions Group plc    AMS   GB0004536594

ADVANCED MEDICAL SOLUTIONS GROUP PLC

(AMS)
  Report  
Delayed Quote. Delayed London Stock Exchange - 06/14 11:35:29 am
325.5 GBp   -0.46%
06/05ADVANCED MEDICAL : Notice of AGM
PU
05/23ADVANCED MEDICAL SOLUTIONS GROUP PLC : Ex-dividend day for final dividend
FA
04/30ADVANCED MEDICAL : Notice of Annual General Meeting and Annual Report
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201620172018201920202021
Sales82,696,9103110117125
EBITDA22,129,530,832,034,136,7
Operating profit (EBIT)19,525,428,628,630,632,5
Pre-Tax Profit (EBT)19,125,328,827,529,733,4
Net income15,720,122,721,923,826,4
P/E ratio30,033,926,232,029,627,2
EPS (GBp )7,389,3610,510,311,212,1
Dividend per Share (GBp )0,921,101,321,391,511,73
Yield0,41%0,35%0,48%0,42%0,46%0,52%
Reference price (GBp )221.75317.75275330330330
Announcement Date03/14/2017
07:52am
03/14/2018
06:01am
03/13/2019
07:01am
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201620172018201920202021
Debt------
Finance51,162,576,481,6101124
Operating income (EBITDA)22,129,530,832,034,136,7
Leverage
(Debt/EBITDA)
------
Capital Expenditure1,522,903,063,863,903,65
Book Value Per Share (BVPS)59,1 PNC71,7 PNC81,0 PNC86,4 PNC97,4 PNC104 PNC
Cash Flow per Share9,33 PNC7,92 PNC9,44 PNC9,40 PNC10,4 PNC11,6 PNC
Announcement Date03/14/2017
07:52am
03/14/2018
06:01am
03/13/2019
07:01am
---
Balance Sheet Analysis
Assessed data source :
© 2019 Thomson Reuters
Financial Ratios

Size 2019e 2020e
Capitalization 708 M GBP -
Entreprise Value (EV) 627 M GBP 607 M GBP
Valuation 2019e 2020e
P/E ratio (Price / EPS) 32,0x 29,6x
Capitalization / Revenue 6,43x 6,05x
EV / Revenue 5,69x 5,19x
EV / EBITDA 19,6x 17,8x
Yield (DPS / Price) 0,42% 0,46%
Price to book (Price / BVPS) 3,82x 3,39x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 25,9% 26,2%
operating Leverage (Delta EBIT / Delta Sales) - 1,15x
Net Margin (Net Profit / Revenue) 19,9% 20,3%
ROA (Net Profit / Asset) 11,3% 11,4%
ROE (Net Profit / Equities) 12,2% 12,2%
Rate of Dividend 13,5% 13,5%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   3,51% 3,33%
Cash Flow / Sales 18,3% 19,1%
Capital Intensity (Assets / Sales) 1,76x 1,78x
Financial Leverage (Net Debt / EBITDA) -2,55x -2,98x
EPS & Dividend